These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy.
    Author: Kleiter I, Schröder M, Lürding R, Schuierer G, Clifford DB, Bogdahn U, Steinbrecher A, Pöschl P.
    Journal: Mult Scler; 2010 Jun; 16(6):749-53. PubMed ID: 20453014.
    Abstract:
    Progressive multifocal leucoencephalopathy has become a growing concern in natalizumab-treated multiple sclerosis patients. Here, we describe a 35-year-old patient who was treated with 34 infusions of natalizumab before complaining about visual deterioration. MRI was non-diagnostic and JC virus testing initially was negative. Electroencephalography showed severe slowing of the right hemisphere, and neuropsychological testing revealed right frontal and temporal deficits. The diagnosis of progressive multifocal leucoencephalopathy was established 2 months later by typical MRI presentation and detection of JC virus DNA in the cerebrospinal fluid. Functional neurological deficits may precede imaging features and should prompt early consideration of progressive multifocal leucoencephalopathy.
    [Abstract] [Full Text] [Related] [New Search]